Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
November 6, 2023
Therapeutic potential of [<sup>177</sup>Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment
Madhav P Yadav, Sanjana Ballal, Marcel Martin, et al.
Annals of Nuclear Medicine
|
March 17, 2019
Preliminary results of biodistribution and dosimetric analysis of [<sup>68</sup>Ga]Ga-DOTA<sup>ZOL</sup>: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseases
Ambreen Khawar, Elisabeth Eppard, Frank Roesch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 21, 2025
Efficacy and Safety of [<sup>177</sup>Lu]Lu-DOTAGA.Glu.(FAPi)<sub>2</sub> Therapy in Patients with Sarcoma
Sanjana Ballal, Mohammad Sakir, Kunal R Chandekar, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 27, 2016
Evaluation of bone-seeking novel radiotracer <sup>68</sup>Ga-NO2AP-Bisphosphonate for the detection of skeletal metastases in carcinoma breast
Averilicia Passah, Madhavi Tripathi, Sanjana Ballal, et al.
Nuklearmedizin. Nuclear Medicine
|
April 29, 2020
[177Lu]Lu-DOTA-zoledronate therapy - first application in a patient with primary osseous metastatic bronchial carcinoma
Barbara Kreppel, Florian Christoph Gaertner, Hojjat Ahmadzadehfar, et al.
Neuropsychobiology
|
February 10, 2011
P-glycoprotein influence on the brain uptake of a 5-HT(2A) ligand: [(18)F]MH.MZ
Ulrich Schmitt, Dianne E Lee, Matthias M Herth, et al.
Molecular Pharmaceutics
|
April 17, 2023
Inhibition of Poly(ADP-ribose) Polymerase Sensitizes [<sup>177</sup>Lu]Lu-DOTAGA.(SA.FAPi)<sub>2</sub>-Mediated Radiotherapy in Triple-Negative Breast Cancer
Guangfa Bao, Huimin Zhou, Sijuan Zou, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 13, 2020
A theranostic approach of [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi PET/CT-guided [<sup>177</sup>Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy
Sanjana Ballal, Madhav Prasad Yadav, Vasko Kramer, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 28, 2024
Head-to-Head Comparison of SSTR Antagonist [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>-LM4 with SSTR Agonist [<sup>68</sup>Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study
Rahul Viswanathan, Sanjana Ballal, Madhav P Yadav, et al.
Diagnostics (Basel, Switzerland)
|
September 28, 2024
[<sup>68</sup>Ga]Ga-DOTAGA-Glu(FAPi)<sub>2</sub> Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging
Julie van Krimpen Mortensen, Simona Mattiussi, Lars Hvass, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
European Journal of Nuclear Medicine and Molecular Imaging
|
November 6, 2023
Therapeutic potential of [<sup>177</sup>Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment
Madhav P Yadav, Sanjana Ballal, Marcel Martin, et al.
Annals of Nuclear Medicine
|
March 17, 2019
Preliminary results of biodistribution and dosimetric analysis of [<sup>68</sup>Ga]Ga-DOTA<sup>ZOL</sup>: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseases
Ambreen Khawar, Elisabeth Eppard, Frank Roesch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 21, 2025
Efficacy and Safety of [<sup>177</sup>Lu]Lu-DOTAGA.Glu.(FAPi)<sub>2</sub> Therapy in Patients with Sarcoma
Sanjana Ballal, Mohammad Sakir, Kunal R Chandekar, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 27, 2016
Evaluation of bone-seeking novel radiotracer <sup>68</sup>Ga-NO2AP-Bisphosphonate for the detection of skeletal metastases in carcinoma breast
Averilicia Passah, Madhavi Tripathi, Sanjana Ballal, et al.
Nuklearmedizin. Nuclear Medicine
|
April 29, 2020
[177Lu]Lu-DOTA-zoledronate therapy - first application in a patient with primary osseous metastatic bronchial carcinoma
Barbara Kreppel, Florian Christoph Gaertner, Hojjat Ahmadzadehfar, et al.
Neuropsychobiology
|
February 10, 2011
P-glycoprotein influence on the brain uptake of a 5-HT(2A) ligand: [(18)F]MH.MZ
Ulrich Schmitt, Dianne E Lee, Matthias M Herth, et al.
Molecular Pharmaceutics
|
April 17, 2023
Inhibition of Poly(ADP-ribose) Polymerase Sensitizes [<sup>177</sup>Lu]Lu-DOTAGA.(SA.FAPi)<sub>2</sub>-Mediated Radiotherapy in Triple-Negative Breast Cancer
Guangfa Bao, Huimin Zhou, Sijuan Zou, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 13, 2020
A theranostic approach of [<sup>68</sup>Ga]Ga-DOTA.SA.FAPi PET/CT-guided [<sup>177</sup>Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy
Sanjana Ballal, Madhav Prasad Yadav, Vasko Kramer, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 28, 2024
Head-to-Head Comparison of SSTR Antagonist [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>-LM4 with SSTR Agonist [<sup>68</sup>Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study
Rahul Viswanathan, Sanjana Ballal, Madhav P Yadav, et al.
Diagnostics (Basel, Switzerland)
|
September 28, 2024
[<sup>68</sup>Ga]Ga-DOTAGA-Glu(FAPi)<sub>2</sub> Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging
Julie van Krimpen Mortensen, Simona Mattiussi, Lars Hvass, et al.
Page
of 7